What's New


December 13, 2016 - Statement by Steve Knievel: HHS Report Suggests That Patient Health Continues to Take a Back Seat to Medical Companies’ Pursuit of Maximum Profits

December 12, 2016 - IP Watch: UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research

December 12, 2016 - The Hill: Gilead CEO’s Apology for Drug Prices are Useless When No Action is Taken

December 11, 2016 - New York Times: Lives and Profits in the Balance: The High Stakes of Medical Patents

December 9, 2016 - New York Times: Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump

For older news, visit the Access to Medicines news archive

Antibiotic Resistance

The lack of effective antibiotics is a global concern with the potential to affect all humans and domesticated animals. It threatens to undermine the effectiveness of modern health care. An ever-widening range of bacteria, causing a spectrum of diseases in humans and animals is becoming resistant to the most available antibiotics. Unchecked, escalating antibiotic resistance will lead to the global spread of untreatable infections and massive deterioration health and loss of life. It will also make most surgery impossible and end organ transplantation and cancer chemotherapy.

As a member of the Antibiotic Resistance Coalition, Public Citizen recognizes that antibiotic resistance threatens to undermine the effectiveness of modern medicine. More and more strains of bacteria are resistant to an ever-rising number of antibiotics, with no new antibiotics on the horizon to treat some of the most serious infections. The change is global and accelerating. Millions of people are infected with antibiotic-resistant bacteria each year; hundreds of thousands lose their lives. The toll will increase.

A number of policies are contributing to the acceleration of the trend, including inadequate regulation and control of the sale and use of antibiotics in animals and humans, unrestrained marketing of the pharmaceutical industry, misuse of antibiotics in human medicine, industrial food animal production and more. The policy frameworks for research and development are further fueling resistance without advancing innovation – failing to ensure access to treatment for all people while allowing excessive and irrational use.



Resources

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.